Ada Health vs Paige AI — HIPAA Compliant Software Comparison

Compare Ada Health and Paige AI side-by-side. See how these HIPAA compliant software solutions stack up in features, categories, and compliance.

Need help choosing the right HIPAA software?

Tell us about your practice and we'll recommend the best tools for you.

Tagline

AI-powered symptom assessment optimized by clinicians

—

Description

Ada Health offers Ada Assess, an AI-powered symptom assessment and care navigation platform sold to health systems, payers and life sciences companies as enterprise solutions, alongside a consumer symptom checker app. Ada Assess is certified as a Class IIa medical device under the EU Medical Device Regulation.

Paige builds AI applications for digital pathology, including Paige Prostate Detect (the first FDA-cleared AI application in pathology), the FullFocus whole-slide image viewer, biomarker tools such as OmniScreen, and the Virchow foundation models, trained on a dataset of almost 7 million digitized pathology slides built through its Memorial Sloan Kettering relationship. Tempus acquired Paige on August 22, 2025 for $81.25 million; Paige continues to operate under its own brand and site.

Tags
—
—
Listing Tier
Free
Free

Request Information

Frequently Asked Questions

Which is better, Ada Health or Paige AI?
Both Ada Health and Paige AI are HIPAA compliant software solutions. The best choice depends on your specific needs, practice size, and workflow requirements. Compare their features side-by-side above to find the right fit.
Is Ada Health HIPAA compliant?
Ada Health is listed in the HIPAA Compliant Software directory. Ada Health offers Ada Assess, an AI-powered symptom assessment and care navigation platform sold to health systems, payers and life sciences companies as enterprise solutions, alongside a consumer symptom checker app. Ada Assess is certified as a Class IIa medical device under the EU Medical Device Regulation.
Is Paige AI HIPAA compliant?
Paige AI is listed in the HIPAA Compliant Software directory. Paige builds AI applications for digital pathology, including Paige Prostate Detect (the first FDA-cleared AI application in pathology), the FullFocus whole-slide image viewer, biomarker tools such as OmniScreen, and the Virchow foundation models, trained on a dataset of almost 7 million digitized pathology slides built through its Memorial Sloan Kettering relationship. Tempus acquired Paige on August 22, 2025 for $81.25 million; Paige continues to operate under its own brand and site.

Related HIPAA Software

Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  

Need help choosing the right HIPAA software?

Tell us about your practice and we'll recommend the best tools for you.